# ABBOTT LABORATORIES (ABT) FY2025 Q1 Balance Sheet

- Company: ABBOTT LABORATORIES (ABT)
- Period: As of 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-04-30, accession number 0001628280-25-021090
- Page: https://plicit.ai/financials/abt/fy2025-q1-balance-sheet
- Chart image: https://plicit.ai/charts/abt-fy2025-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 81,448,000,000 US dollars
- **Current assets**: 23,153,000,000 US dollars
- **Non-current assets**: 58,295,000,000 US dollars
- **Liabilities (calculated)**: 32,384,000,000 US dollars
- **Current liabilities**: 13,004,000,000 US dollars
- **Non-current liabilities**: 19,380,000,000 US dollars
- **Equity**: 49,064,000,000 US dollars
- **Noncontrolling interest**: 253,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Property and equipment, at cost**: 23,418,000,000 US dollars. Part of Net property and equipment, drawn as one net amount.
- **Less: accumulated depreciation and amortization**: negative 12,486,000,000 US dollars. Part of Net property and equipment, drawn as one net amount.
- **Trade receivables, less allowances of $449 in 2025 and $439 in 2024**: 7,327,000,000 US dollars
- **Cash and cash equivalents**: 6,532,000,000 US dollars
- **Finished products**: 4,063,000,000 US dollars
- **Prepaid expenses and other receivables**: 2,343,000,000 US dollars
- **Materials**: 1,686,000,000 US dollars
- **Work in process**: 890,000,000 US dollars
- **Short-term investments**: 312,000,000 US dollars
- **Goodwill**: 23,359,000,000 US dollars
- **Deferred income taxes and other assets**: 16,836,000,000 US dollars
- **Net property and equipment**: 10,932,000,000 US dollars
- **Intangible assets, net of amortization**: 6,261,000,000 US dollars
- **Investments**: 907,000,000 US dollars
- **Other accrued liabilities**: 5,600,000,000 US dollars
- **Trade accounts payable**: 4,214,000,000 US dollars
- **Salaries, wages and commissions**: 1,167,000,000 US dollars
- **Dividends payable**: 1,032,000,000 US dollars
- **Current portion of long-term debt**: 506,000,000 US dollars
- **Income taxes payable**: 485,000,000 US dollars
- **Long-term debt**: 12,736,000,000 US dollars
- **Post-employment obligations, deferred income taxes and other long-term liabilities**: 6,644,000,000 US dollars
- **Earnings employed in the business**: 47,715,000,000 US dollars
- **Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2025: 1,995,858,606; 2024: 1,991,472,630**: 25,125,000,000 US dollars
- **Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued**: 0 US dollars
- **Noncontrolling Interests in Subsidiaries**: 253,000,000 US dollars
- **Common shares held in treasury, at cost — Shares: 2025: 256,021,416; 2024: 259,774,639**: negative 16,612,000,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 7,417,000,000 US dollars
- **Gross equity (calculated)**: 73,093,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.